Tumor M2-PK: a tool for metabolic profiling of gastric cancer

Comparison of sensitivities of Tumor M2-PK, CEA, CA19-9 and CA 72.4 in gastric tumors

nm = non metastasized; m = metastasized; t = total
n.d.a. = no data available

gastriccancer

Sensitivities for combination of Tumor M2-PK with classical tumor markers

Schulze, 2000: Tumor M2-PK + Ca 72-4: 82 %

Tumor M2-PK concentrations were measured with a sandwich ELISA from
ScheBo Biotech AG, Giessen, Germany.

CEA, CA-19-9 and CA 72-4 were determined using, Cobras Core II from Roche Diagnostics, Mannheim, enzymun Test-ES 600 Immunology Multianalyzer as well as tests from Sorin Diagnostics, Saluggia.